Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(incobotulinumtoxinA)
358 results
  • High-efficiency Combination Treatment of Submental Neck Fullness. [Journal Article]
    Plast Reconstr Surg Glob Open 2019; 7(7):e2306Cheng CKL
  • CONCLUSIONS: Delivering MFU-V using the GADA technique effectively tightens submental and submandibular soft tissues. When combined with incobotulinumtoxinA, muscles in the chin and perioral area are relaxed. Thus, GADA yields significant clinical improvement and patient satisfaction.
  • Botulinum Toxin: Pharmacology and Injectable Administration for the Treatment of Primary Hyperhidrosis. [Review]
    J Am Acad Dermatol 2019Nawrocki S, Cha J
  • Hyperhidrosis is a dermatological condition defined by excessive sweating beyond thermoregulatory needs with significant effects on patients' quality of life. Hyperhidrosis is categorized as primary or secondary: primary hyperhidrosis is mostly focal and idiopathic, whereas secondary hyperhidrosis is commonly generalized and caused by an underlying medical condition or use of medications. Various…
  • Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy. [Journal Article]
    J Stroke Cerebrovasc Dis 2020; 29(1):104481Ro T, Ota T, … Oikawa O
  • CONCLUSIONS: The comparison of predose values versus 2-week postdose values indicated that the effect of botulinum toxin formulation would not lessen after repeated injections with continuous improvements of Modified Ashworth Scale and range of motion. The comparison of predose values versus the first predose value also suggested that multiple injections of botulinum toxin formulation could be more effective in reducing spasticity and increasing the range of motion than a single injection.
  • Therapy of Sialorrhea with Botulinum Neurotoxin. [Review]
    Neurol Ther 2019; 8(2):273-288Jost WH, Bäumer T, … Bavikatte G
  • Botulinum neurotoxin (BoNT) is considered the treatment of choice for various symptoms and diseases such as focal dystonia and focal spasticity. The effects of BoNT on the salivary glands have also been known for years, but their use was limited because of a lack of approval studies. Now the indication of sialorrhea is approved in some countries for incobotulinumtoxinA, such as the USA and Europe…
New Search Next